rs1943620

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181351.5(NCAM1):​c.53-7808G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.419 in 152,068 control chromosomes in the GnomAD database, including 14,894 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 14894 hom., cov: 32)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.17

Publications

12 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.616 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.53-7808G>A intron_variant Intron 1 of 19 ENST00000316851.12 NP_851996.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.53-7808G>A intron_variant Intron 1 of 19 5 NM_181351.5 ENSP00000318472.8

Frequencies

GnomAD3 genomes
AF:
0.419
AC:
63618
AN:
151950
Hom.:
14871
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.623
Gnomad AMI
AF:
0.243
Gnomad AMR
AF:
0.436
Gnomad ASJ
AF:
0.360
Gnomad EAS
AF:
0.449
Gnomad SAS
AF:
0.401
Gnomad FIN
AF:
0.210
Gnomad MID
AF:
0.373
Gnomad NFE
AF:
0.328
Gnomad OTH
AF:
0.398
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.419
AC:
63689
AN:
152068
Hom.:
14894
Cov.:
32
AF XY:
0.413
AC XY:
30676
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.623
AC:
25844
AN:
41498
American (AMR)
AF:
0.436
AC:
6651
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.360
AC:
1247
AN:
3468
East Asian (EAS)
AF:
0.448
AC:
2316
AN:
5166
South Asian (SAS)
AF:
0.400
AC:
1925
AN:
4818
European-Finnish (FIN)
AF:
0.210
AC:
2227
AN:
10588
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.328
AC:
22303
AN:
67952
Other (OTH)
AF:
0.400
AC:
844
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1755
3511
5266
7022
8777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.362
Hom.:
42710
Bravo
AF:
0.447
Asia WGS
AF:
0.467
AC:
1622
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.038
DANN
Benign
0.38
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1943620; hg19: chr11-113065293; API